Ernexa Therapeutics Inc.
1035 Cambridge Street, Suite 18A
Cambridge, MA 02141
June 16, 2025
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
| Re: | Ernexa Therapeutics Inc. | |
| Registration Statement on Form S-3 | ||
| Filed June 11, 2025 | ||
| File No. 333-287954 |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Ernexa Therapeutics Inc. hereby respectfully requests acceleration of the effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 4:30 p.m. Eastern Time, June 18, 2025, or as soon as practicable thereafter.
| Very truly yours, | ||
| Ernexa Therapeutics Inc. | ||
| By: | /s/ Sandra Gurrola | |
| Sandra Gurrola | ||
| Senior Vice President, Finance | ||